Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12202128 | PMC |
| http://dx.doi.org/10.1055/a-2610-3096 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Avoiding Electrocautery: Hemostatic Agents for Perioperative Bleeding in Mohs Micrographic Surgery.
Dermatol Surg
September 2025
Epiphany Dermatology, Dallas, Texas.
Background: Bleeding remains a frequent complication during Mohs micrographic surgery, particularly among patients receiving anticoagulant or antiplatelet therapy. The growing use of these medications has prompted increased exploration of adjunctive methods to improve perioperative hemostasis.
Objective: To systematically review the literature on topically and locally administered hemostatic agents used to reduce bleeding in Mohs micrographic surgery.
An in situ fused adhesive with integrated antibacterial and hemostatic functionalities for urgent respiratory fistula sealing and enhanced wound repair.
Acta Biomater
August 2025
State Key Laboratory of Materials-Oriented Chemical Engineering, Nanjing Tech University, Nanjing 211816, PR China. Electronic address:
Respiratory fistulas remain clinically challenging in endoscopic treatment due to the absence of convenient non-compressive sealing materials. Here, we developed an in situ self-fused powder adhesive (PP powder) to address this limitation. This material integrates the adaptive conformability of hydrogel microparticles with the pressure-resistant sealing capability of bulk hydrogels via water-triggered self-assembly.
View Article and Find Full Text PDFAn endoscopy deliverable hydrogel dry powder for sealing and repairing gastric perforation.
Acta Biomater
August 2025
National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
Gastric perforation (GP) is characterized by full-thickness injury of the stomach wall, a severe and potentially life-threatening gastrointestinal disease. However, current treatment, including surgical sutures and endoscopic closure, faces limitations, achieving complete sealing of the perforation and favorable healing remains a great challenge and an acute clinical demand. Here, we report a hydrogel dry powder (PPCL@Mg) for the minimally invasive treatment of GP, which can be delivered to target perforation wounds by spraying via an endoscope, and rapidly absorbing interfacial water and spontaneously forming a hydrogel.
View Article and Find Full Text PDFSticky Bone: Advances and Applications.
Int J Nanomedicine
August 2025
Hospital of Stomatology, Jilin University, Changchun, Jilin, 130021, People's Republic of China.
Sticky bone is a new type of composite biological material in the field of dental implantation and restoration in recent years, which is usually composed of Autologous Fibrin Glue (AFG) or injectable-platelet rich fibrin (i-PRF) is prepared in combination with different types of bone augmentation materials, such as granular or powdered bone substitutes, providing a solution for bone regeneration that integrates growth factor release with bone scaffold functionality. Its unique gel texture ensures precise adhesion at the site of bone defects and does not fall apart due to external forces. This property not only enhances the stability of the bone graft, but also accelerates the regeneration and healing of bone tissue by providing an ideal environment for cell attachment and proliferation.
View Article and Find Full Text PDFSingle-center, prospective study evaluating safety and efficacy of a new endoscopic hemostat system in non-variceal upper gastrointestinal bleeding.
Endosc Int Open
July 2025
Dept. of Medical Gastroenterology, Asian Institute of Gastroenterology (AIG Hospitals), Hyderabad, India.
Background And Study Aims: Endoscopic spray therapy has been shown to be effective and safe in managing upper gastrointestinal bleeding (UGIB). We aimed to evaluate safety and efficacy of the novel powder-based Resolv Endoscopic Hemostat System in managing UGIB.
Patients And Methods: This was a single-center, prospective, single-arm study conducted from July 2022 to February 2023.